The ADIPOQ gene has been implicated in the etiology of hypertension. However, the results have been inconsistent. In this study, a meta-analysis was performed to assess the associations of ADIPOQ polymorphisms with hypertension risk among the Chinese. Published literature from PubMed, CNKI and Wanfang Data were retrieved. Pooled odds ratio (OR) with 95 % confidence interval (CI) was calculated using fixed- or random-effects model. Six studies (1,812 cases and 2,631 controls) for rs2241766 polymorphism and four studies (1,449 cases and 2,175 controls) for rs1501299 polymorphism were identified. A marginally significant association was observed for rs2241766 polymorphism under recessive genetic model (GG vs. GT+TT: OR = 1.22, 95 % CI 1.01–1.48) and for rs1501299 polymorphism under heterogeneous co-dominant model (TG vs. GG: OR = 0.86, 95 % CI 0.75–0.99) and dominant model (TT+TG vs. GG: OR = 0.85, 95 % CI 0.74–0.98). In addition, under other genetic models, there was no significant association for rs2241766 polymorphism (GG vs. TT: OR = 1.20, 95 % CI 0.98–1.48; GT vs. TT: OR = 0.97, 95 % CI 0.85–1.10; GG+GT vs. TT: OR = 1.01, 95 % CI 0.90–1.15) and for rs1501299 polymorphism (TT vs. GG: OR = 0.82, 95 % CI 0.62–1.08; TT vs. TG+GG: OR = 0.87, 95 % CI 0.66–1.14). However, the associations above were not robust by sensitivity analysis. The present meta-analysis indicated the limited evidence of the significant associations between ADIPOQ gene polymorphisms and hypertension susceptibility among the Chinese.
Hypertension ADIPOQPolymorphism Meta-analysis
This is a preview of subscription content, log in to check access.
This study was supported by National “Twelfth Five-Year” Plan for Science & Technology Support Program (2012BAI03B03), Independent Innovation Foundation of Shandong University (2010GN046), and the Foundation for Outstanding Young Scientist in Shandong Province (BS2011YY026).
Conflict of interest
Wu Y, Huxley R, Li L et al (2008) Prevalence, awareness, treatment, and control of hypertension in China: data from the China national nutrition and health survey 2002. Circulation 118:2679–2686CrossRefPubMedGoogle Scholar
Harrison M, Maresso K, Broeckel U (2008) Genetic determinants of hypertension: an update. Curr Hypertens Rep 10:488–495CrossRefPubMedGoogle Scholar
Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 4:459–469Google Scholar
Chow WS, Cheung BM, Tso AW et al (2007) Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 6:1455–1461CrossRefGoogle Scholar
Yan WL, Chen SF, Huang JF et al (2006) Common SNPs of APM1 gene are not associated with hypertension or obesity in Chinese population. Biomed Environ Sci 19:179–184PubMedGoogle Scholar
Jeng JR (2007) Plasma adiponectin, T94G gene polymorphism and PAI-1 in patients with and without hypertension. Cardiology 107:30–37CrossRefPubMedGoogle Scholar
Tang XM, Li JQ, Wu LR et al (2008) Relationship between adiponectin +45 nucleotide T/G polymorphism and essential hypertension. Tianjin Med J 36:762–764Google Scholar
Wang ZL, Xia B, Jiang L et al (2008) Association between adiponectin gene polymorphisms and hypertension. J New Med 18:25–29Google Scholar
Leu HB, Chung CM, Lin SJ et al (2011) Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 6:e19999CrossRefPubMedPubMedCentralGoogle Scholar
Ong KL, Li M, Tso AW et al (2010) Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 163:251–257CrossRefPubMedGoogle Scholar
Zhang ZB, Yu LJ, Yang KJ et al (2011) Association between single nucleotide polymorphisms (SNPs) at the promoter of adiponectin gene and essential hypertension in Chinese Korean and Han of Yanbian region. Hereditas (Beijing) 33:54–59CrossRefGoogle Scholar
Jia M, Qiao BM, Zhang Z et al (2008) Study on correlation of genetic polymorphism of adiponectin promoter and adiponectin level with hypertension and its complications. Chin J Lab Diagn 12:222–226Google Scholar
Boccia S, De Feo E, Gallì P et al (2010) A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol 25:765–775CrossRefPubMedGoogle Scholar
Zhao T, Zhao J (2011) Genetic effects of adiponectin on blood lipids and blood pressure. Clin Endocrinol (Oxf) 74:214–222CrossRefGoogle Scholar
Yu Z, Han S, Cao X et al (2011) Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring). doi:10.1038/oby.2011.148Google Scholar
Li Y, Li X, Shi L et al (2011) Association of Adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case–control studies. PLoS One 6:e19686CrossRefPubMedPubMedCentralGoogle Scholar